NO982754L - Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter - Google Patents
Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenterInfo
- Publication number
- NO982754L NO982754L NO982754A NO982754A NO982754L NO 982754 L NO982754 L NO 982754L NO 982754 A NO982754 A NO 982754A NO 982754 A NO982754 A NO 982754A NO 982754 L NO982754 L NO 982754L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- preparation
- phospholipid
- antiviral drugs
- phosphonocarboxylic acids
- Prior art date
Links
- -1 Phospholipid derivatives of phosphonocarboxylic acids Chemical class 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
- C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995147023 DE19547023A1 (de) | 1995-12-15 | 1995-12-15 | Neue Phospholipid-Derivate von Phosphonocarbonsäuren, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel |
DE1996143416 DE19643416A1 (de) | 1996-10-22 | 1996-10-22 | Neue Phospholipid-Derivate von Phosphonocarbonsäuren, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel |
PCT/EP1996/005647 WO1997022613A1 (de) | 1995-12-15 | 1996-12-16 | Phospholipid-derivate von phosphonocarbonsäuren, deren herstellung sowie deren verwendung als antivirale arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982754D0 NO982754D0 (no) | 1998-06-15 |
NO982754L true NO982754L (no) | 1998-08-13 |
Family
ID=26021319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982754A NO982754L (no) | 1995-12-15 | 1998-06-15 | Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter |
Country Status (23)
Country | Link |
---|---|
US (1) | US6136797A (es) |
EP (1) | EP0868425B1 (es) |
JP (1) | JP2000515113A (es) |
KR (1) | KR20000064374A (es) |
CN (1) | CN1085672C (es) |
AR (1) | AR005089A1 (es) |
AT (1) | ATE278698T1 (es) |
AU (1) | AU714236B2 (es) |
BR (1) | BR9612133A (es) |
CA (1) | CA2240366A1 (es) |
CZ (1) | CZ291823B6 (es) |
DE (1) | DE59611111D1 (es) |
ES (1) | ES2230574T3 (es) |
HU (1) | HUP0001534A3 (es) |
IL (1) | IL124790A (es) |
NO (1) | NO982754L (es) |
NZ (1) | NZ325259A (es) |
PL (1) | PL186402B1 (es) |
RU (1) | RU2166508C2 (es) |
SK (1) | SK75698A3 (es) |
TR (1) | TR199801082T2 (es) |
TW (1) | TW343975B (es) |
WO (1) | WO1997022613A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19547022A1 (de) * | 1995-12-15 | 1997-06-19 | Boehringer Mannheim Gmbh | Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel |
US6835721B2 (en) * | 1999-02-01 | 2004-12-28 | Eisai Co., Ltd. | Immunomodulatory compounds and methods of use thereof |
US20040006242A1 (en) | 1999-02-01 | 2004-01-08 | Hawkins Lynn D. | Immunomodulatory compounds and method of use thereof |
US6551600B2 (en) * | 1999-02-01 | 2003-04-22 | Eisai Co., Ltd. | Immunological adjuvant compounds compositions and methods of use thereof |
US7915238B2 (en) * | 1999-02-01 | 2011-03-29 | Eisai R & D Management Co., Ltd. | Immunomodulatory compounds and methods of use thereof |
US6818057B2 (en) | 1999-03-02 | 2004-11-16 | Construction Research & Technology Gmbh | Retarder for calcium sulfoaluminate cements |
US20040172288A1 (en) * | 2003-02-27 | 2004-09-02 | Korn Lawrence D. | Method for disseminating medical alert information |
US20070292418A1 (en) * | 2005-04-26 | 2007-12-20 | Eisai Co., Ltd. | Compositions and methods for immunotherapy |
WO2006116423A2 (en) | 2005-04-26 | 2006-11-02 | Eisai Co., Ltd | Compositions and methods for cancer immunotherapy |
EP2826369A3 (en) * | 2008-11-06 | 2015-03-18 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
EP2876094A1 (en) | 2014-04-03 | 2015-05-27 | Basf Se | Cement and calcium sulphate based binder composition |
KR101658048B1 (ko) | 2014-06-25 | 2016-09-20 | 한국생명공학연구원 | 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물 |
CA3105038A1 (en) * | 2018-06-26 | 2020-01-02 | Tsrl, Inc. | Metabolically stable prodrugs |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0050327B1 (de) * | 1980-10-21 | 1984-06-20 | Roche Diagnostics GmbH | Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
DE3929217A1 (de) * | 1989-09-02 | 1991-03-07 | Boehringer Mannheim Gmbh | Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide |
DE4026265A1 (de) * | 1990-08-20 | 1992-02-27 | Boehringer Mannheim Gmbh | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel |
US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
DE19547022A1 (de) * | 1995-12-15 | 1997-06-19 | Boehringer Mannheim Gmbh | Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel |
-
1996
- 1996-12-14 TW TW085115475A patent/TW343975B/zh active
- 1996-12-16 SK SK756-98A patent/SK75698A3/sk unknown
- 1996-12-16 AR ARP960105701A patent/AR005089A1/es not_active Application Discontinuation
- 1996-12-16 AU AU13730/97A patent/AU714236B2/en not_active Ceased
- 1996-12-16 AT AT96943972T patent/ATE278698T1/de not_active IP Right Cessation
- 1996-12-16 NZ NZ325259A patent/NZ325259A/xx unknown
- 1996-12-16 JP JP09522501A patent/JP2000515113A/ja not_active Ceased
- 1996-12-16 CN CN96180011A patent/CN1085672C/zh not_active Expired - Fee Related
- 1996-12-16 CZ CZ19981810A patent/CZ291823B6/cs not_active IP Right Cessation
- 1996-12-16 EP EP96943972A patent/EP0868425B1/de not_active Expired - Lifetime
- 1996-12-16 RU RU98113304/04A patent/RU2166508C2/ru not_active IP Right Cessation
- 1996-12-16 KR KR1019980704352A patent/KR20000064374A/ko not_active Application Discontinuation
- 1996-12-16 DE DE59611111T patent/DE59611111D1/de not_active Expired - Fee Related
- 1996-12-16 IL IL12479096A patent/IL124790A/en not_active IP Right Cessation
- 1996-12-16 BR BR9612133A patent/BR9612133A/pt not_active IP Right Cessation
- 1996-12-16 ES ES96943972T patent/ES2230574T3/es not_active Expired - Lifetime
- 1996-12-16 HU HU0001534A patent/HUP0001534A3/hu unknown
- 1996-12-16 CA CA002240366A patent/CA2240366A1/en not_active Abandoned
- 1996-12-16 WO PCT/EP1996/005647 patent/WO1997022613A1/de active IP Right Grant
- 1996-12-16 US US09/077,891 patent/US6136797A/en not_active Expired - Fee Related
- 1996-12-16 TR TR1998/01082T patent/TR199801082T2/xx unknown
- 1996-12-16 PL PL96327173A patent/PL186402B1/pl not_active IP Right Cessation
-
1998
- 1998-06-15 NO NO982754A patent/NO982754L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL124790A (en) | 2002-04-21 |
DE59611111D1 (de) | 2004-11-11 |
WO1997022613A1 (de) | 1997-06-26 |
KR20000064374A (ko) | 2000-11-06 |
JP2000515113A (ja) | 2000-11-14 |
SK75698A3 (en) | 1999-03-12 |
EP0868425B1 (de) | 2004-10-06 |
TW343975B (en) | 1998-11-01 |
NZ325259A (en) | 2000-01-28 |
ATE278698T1 (de) | 2004-10-15 |
CA2240366A1 (en) | 1997-06-26 |
IL124790A0 (en) | 1999-01-26 |
PL186402B1 (pl) | 2004-01-30 |
CN1085672C (zh) | 2002-05-29 |
US6136797A (en) | 2000-10-24 |
HUP0001534A2 (hu) | 2001-05-28 |
BR9612133A (pt) | 1999-07-13 |
CZ291823B6 (cs) | 2003-06-18 |
PL327173A1 (en) | 1998-11-23 |
RU2166508C2 (ru) | 2001-05-10 |
AU1373097A (en) | 1997-07-14 |
CZ181098A3 (cs) | 1998-10-14 |
HUP0001534A3 (en) | 2002-08-28 |
ES2230574T3 (es) | 2005-05-01 |
CN1209133A (zh) | 1999-02-24 |
AU714236B2 (en) | 1999-12-23 |
EP0868425A1 (de) | 1998-10-07 |
AR005089A1 (es) | 1999-04-14 |
TR199801082T2 (xx) | 1998-09-21 |
NO982754D0 (no) | 1998-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
NO20021111D0 (no) | Anvendelse av 5-O-deoaminyl-6-O-metylerytronolid A-derivater for fremstilling av biologisk aktive produkter | |
NO981008D0 (no) | Farmasöytisk formulering | |
NO892936L (no) | Fremgangsmaate for fremstilling av furanderivater. | |
NO984878D0 (no) | Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere | |
NO953367L (no) | Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler | |
EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
NO982754L (no) | Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter | |
NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
EE9800145A (et) | Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena | |
NO981537D0 (no) | Fremgangsmåte for fremstilling av antimalariamedikamenter | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
NO955082D0 (no) | Fremgangsmåte for fremstilling av glutardialdehyd | |
NO306993B1 (no) | Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO982755D0 (no) | Kovalente lipid-fosfonokarboksylsyrederivater og deres anvendelse som antivirusmedikamenter | |
NO980471L (no) | Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav | |
TR28699A (tr) | Imidazopiridin türevlerinin hazirlanmasi icin yöntem. | |
NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
NO894516D0 (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
NO981798D0 (no) | FremgangsmÕte for fremstilling av faste legemiddelformer | |
NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
ZA945651B (en) | Use of benzenesulphonzlindole derivatives for the preparation of medicines | |
NO894707L (no) | Fremgangsmaate for fremstilling av benzoksazinderivater. | |
NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater | |
BR9603673A (pt) | Preparado de combinação farmacêutica compreendendo cetoprofeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |